Transcranial Pulsed Ultrasound

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Transcranial Pulsed Ultrasound (TPU) uses low intensity, low frequency ultrasound (LILFU) as a method to stimulate the brain. In 2002, Dr. Alexander Bystritsky first proposed the idea that this methodology contained therapeutic benefits.[1] Beginning in 2008, Dr. William Tyler and his research team from Arizona State University began an investigation and development of this alternative neuromodulation without the harmful effects and risks of invasive surgery. They discovered that this low-power ultrasound is able to stimulate high neuron activity which allows for the manipulation of the brain waves through an external source. Unlike Deep brain stimulation or Vagus nerve stimulation, which use implants and electrical impulses, TPU is a noninvasive and focused procedure that does not require the implantation of electrodes that could damage the nervous tissue. Its use is applicable in various fields including but not limited to medical and military science. Although this technology holds great potential to introducing new and beneficial alternatives to conventional brain manipulation, it is a relatively young science and has certain obstructions to its full development such as a lack of complete understanding and control of every safety measure.[2]

Research and Applications[edit]

Most of the research as of 2010 revolved around projects to utilize TPU as a method of treating neural disorders and improving cognitive function. However, in 2012 Dr. Tyler also began research on ultrasound's potential to stopping seizures.[3] Dr. Tyler and his team still continue to improve their knowledge of brain stimulation therapy and hope to provide a strong foundation in the implementation of such methods.[4]

Medical Field[edit]

Scientists continue to test a variety of mammals such as humans, monkeys and mice on positively effecting the treatment of epilepsy, Parkinson's disease, chronic pain, coma, dystonia, psychoses and depression through the less harmful, unconventional approach of TPU. Although the potential for this treatment covers a wide variety of benefits, it is a young science and will take a great amount of time to become officially implemented into our medical society.[2]

Military[edit]

Defense Advanced Research Projects Agency (DARPA) is undergoing research to develop a helmet that could control the minds of soldiers through the use of TPU. It would have the potential to control a soldier's stress and anxiety levels with the click of a remote controlled button.[5] Sound waves would target specific areas of the brain to stimulate activity in regions only a few cubic millimeters in size. This would allow them to target very specific areas of the brain with great accuracy and without inflicting damage to its surroundings. A prototype of this device is currently being worked upon to better the ability and potential of soldiers.[6]

Testing[edit]

Conventional ultrasound used for anatomical analysis typically uses a wave frequency of about 20 MHz to penetrate the bodily tissue and produce images. In comparison, the low frequency of TPU has a sub-thermal exposure of about 5.7 MHz. By significantly reducing the wave frequency, excitable tissue can be manipulated without overexposure or detectable damage. Scientists have discovered that focusing on targeted brain regions in animals has been proven to alter their behavior, their cells' electrical properties (electrophysiology), and their synaptic plasticity, which is essentially the neuron's ability to function.[1]

For instance, when focused on the motor cortex of mice, TPU has been shown to induce paw movements without changing the structure or function of that area of the brain. This proves that this method is capable of controlling brain activity at a high cognitive level. It is clear that shorter waves are able to activate neuron activity while longer waves inhibit it. However, the mechanism responsible for this reaction is yet to be discovered. A recent leading hypothesis is the mechanical manipulation of stretch-sensitive membranes actually stimulates certain voltage-gated ion channels, such as sodium or calcium, thus modulating neuronal activity.[1]

Limitations[edit]

Clinical trials have been used to determine any outstanding harmful effects. Although no subjects have displayed long-term neurological abnormalities as a result of these tests, this is a relatively new procedure and has not been studied enough to predict long term side effects. Even though it is a safer alternative to surgery because it is non-invasive, ultrasound always holds the potential to unintentionally disarrange the neurons in a harmful way and cause minor hemorrhages after long-term exposure.[7]

Therapeutic Benefits[edit]

Opposing high-frequency ultrasound, LILFU holds the following benefits: lower absorption in tissue, greater physical penetration depth in tissue, stronger particle deflections, significantly better acoustic penetration and power in bone, greater influence in kinetic effects, immediate/short-term effect results, longer/persistent effects after procedure and a higher degree of patient safety.[8]

References[edit]

  1. ^ a b c Hameroff, Stewart. "Transcranial ultrasound (TUS) effects on mental states: A pilot study". Elsevier. Retrieved 25 October 2013. 
  2. ^ a b "Ultrasound Shown To Exert Remote Control Of Brain Circuits". ScienceDaily. Brain Circuits. Retrieved 23 October 2013. 
  3. ^ Tyler, William. "Our Research in the News". Tyler Laboratory. Retrieved 10 November 2013. 
  4. ^ Tyler, William. "Research Program Summary". The Virginia Tech Carilion School of Medicine and Research Institute. Retrieved 23 October 2013. 
  5. ^ "Transcranial Pulsed Ultrasound – By DARPA". wishusucess. Retrieved 25 October 2013. 
  6. ^ Ishtiaq, Ahzam. "TRANSCRANIAL PULSED ULTRASOUND (HELMET REVOLUTION)". Phisbook. Retrieved 25 October 2013. 
  7. ^ Daffertshofer, M. "Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial". PubMed. Retrieved 13 November 2013. 
  8. ^ "Why low-frequency Ultrasound?". UltraPuls. Retrieved 13 November 2013.